Literature DB >> 28211990

Homozygous mutation in PRUNE1 in an Oji-Cree male with a complex neurological phenotype.

Gregory Costain1,2, Andrea Shugar2,3, Pradeep Krishnan4, Saadet Mahmutoglu2, Suzanne Laughlin4, Peter Kannu2,5.   

Abstract

The PRUNE1 gene encodes a member of the phosphoesterases (DHH) protein superfamily that is highly expressed in the human fetal brain and involved in the regulation of cell migration. Homozygous or compound heterozygous PRUNE1 mutations were recently identified in five individuals with brain malformations from four families. We present a case of a 2-year-old male with a complex neurological phenotype and abnormalities on brain MRI. Re-annotation of clinical whole-exome sequencing data revealed a homozygous likely pathogenic variant in PRUNE1 (c.521-2A>G). These results further delineate a new PRUNE1-related syndrome, and highlight the importance of periodic data re-annotation in individuals who remain without a diagnosis after undergoing genome-wide testing.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Cree; DRES17; HTCD37; Ojibwe; PRUNE; PRUNE1; brain structure; founder effect; infantile spasms; whole-exome sequencing

Mesh:

Year:  2017        PMID: 28211990     DOI: 10.1002/ajmg.a.38066

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  5 in total

1.  Periodic reanalysis of whole-genome sequencing data enhances the diagnostic advantage over standard clinical genetic testing.

Authors:  Gregory Costain; Rebekah Jobling; Susan Walker; Miriam S Reuter; Meaghan Snell; Sarah Bowdin; Ronald D Cohn; Lucie Dupuis; Stacy Hewson; Saadet Mercimek-Andrews; Cheryl Shuman; Neal Sondheimer; Rosanna Weksberg; Grace Yoon; M Stephen Meyn; Dimitri J Stavropoulos; Stephen W Scherer; Roberto Mendoza-Londono; Christian R Marshall
Journal:  Eur J Hum Genet       Date:  2018-02-16       Impact factor: 4.246

2.  High prevalence of multilocus pathogenic variation in neurodevelopmental disorders in the Turkish population.

Authors:  Tadahiro Mitani; Sedat Isikay; Alper Gezdirici; Elif Yilmaz Gulec; Jaya Punetha; Jawid M Fatih; Isabella Herman; Gulsen Akay; Haowei Du; Daniel G Calame; Akif Ayaz; Tulay Tos; Gozde Yesil; Hatip Aydin; Bilgen Geckinli; Nursel Elcioglu; Sukru Candan; Ozlem Sezer; Haktan Bagis Erdem; Davut Gul; Emine Demiral; Muhsin Elmas; Osman Yesilbas; Betul Kilic; Serdal Gungor; Ahmet C Ceylan; Sevcan Bozdogan; Ozge Ozalp; Salih Cicek; Huseyin Aslan; Sinem Yalcintepe; Vehap Topcu; Yavuz Bayram; Christopher M Grochowski; Angad Jolly; Moez Dawood; Ruizhi Duan; Shalini N Jhangiani; Harsha Doddapaneni; Jianhong Hu; Donna M Muzny; Dana Marafi; Zeynep Coban Akdemir; Ender Karaca; Claudia M B Carvalho; Richard A Gibbs; Jennifer E Posey; James R Lupski; Davut Pehlivan
Journal:  Am J Hum Genet       Date:  2021-09-28       Impact factor: 11.025

3.  Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies in a consanguineous Iranian family is associated with a homozygous start loss variant in the PRUNE1 gene.

Authors:  Mehdi Agha Gholizadeh; Mina Mohammadi-Sarband; Fatemeh Fardanesh; Masoud Garshasbi
Journal:  BMC Med Genomics       Date:  2022-04-04       Impact factor: 3.063

4.  PRUNE Syndrome Is a New Neurodevelopmental Disorder: Report and Review.

Authors:  Majid Alfadhel; Marwan Nashabat; Khalid Hundallah; Amal Al Hashem; Ahmed Alrumayyan; Brahim Tabarki
Journal:  Child Neurol Open       Date:  2018-01-11

5.  NMIHBA results from hypomorphic PRUNE1 variants that lack short-chain exopolyphosphatase activity.

Authors:  Harikiran Nistala; John Dronzek; Claudia Gonzaga-Jauregui; Shek Man Chim; Saathyaki Rajamani; Samer Nuwayhid; Dennis Delgado; Elizabeth Burke; Ender Karaca; Matthew C Franklin; Prasad Sarangapani; Michael Podgorski; Yajun Tang; Melissa G Dominguez; Marjorie Withers; Ron A Deckelbaum; Christopher J Scheonherr; William A Gahl; May C Malicdan; Brian Zambrowicz; Nicholas W Gale; Richard A Gibbs; Wendy K Chung; James R Lupski; Aris N Economides
Journal:  Hum Mol Genet       Date:  2021-01-06       Impact factor: 6.150

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.